Skip to Content
Søk Menu

Cancer Epigenomics Improve the Overall Survival and the Quality of Life

Marc Eid and Karl Semaan from Dana-Farber Cancer Institute present in this MEDtalk their work on the non-invasive detection of aggressive variants of renal cell carcinoma and prostate cancer using epigenomic liquid biopsy.
Marc Eid og Karl Semaan

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Relaterat innehåll

Norwegian Perspectives on Urogenital Cancer at ESMO 2024

/ BestPractice Nordic
BlåscancerESMO24NjurcancerProstatacancer
Gedske Daugaard

Enzalutamide plus Radium223 Treatment as First-Line for mCRPC in a Nordic Perspective

/ Gedske Daugaard
ESMO24Prostatacancer Play the Video 5:55
Silke Gillessen

PEACE-3 study: Enzalutamide and Ra-223 as First-Line Therapy for mCRPC

/ Silke Gillessen
ESMO24Prostatacancer Play the Video 11:05

Androgen Receptor Pathway Inhibitors (ARPIs) Are Superior to Taxanes for Castrate-Resistant Metastatic Prostate Cancer

/ Henrik Grönberg
ESMO24Prostatacancer Play the Video 02:35
Daniel Heinrich

Highlights from ESMO 2024: More Intelligent Choice of Treatment in the Future

/ Daniel Heinrich
BlåscancerESMO24NjurcancerProstatacancer Play the Video 4:25
Fred Saad

Darolutamide May Be an Effective Alternative Treatment Option for mHSPC

/ Fred Saad
ESMO24Prostatacancer Play the Video 3:46

Get in the Perineum! – Refinement of Prostate Biopsy Technique for Patient Safety and Antibiotic Stewardship

/ Lars Boesen
Prostatacancer
Jerome Leow

PSMA PET Staging Significantly Improves Prognosis in Pelvic Node-Positive Prostate Cancer

/ Boon Yang Jerome Leow
Prostatacancer Play the Video 07:19
Thorgerdur Palsdottir

The Capio Model for Prostate Cancer Diagnostics

/ Thorgerdur Palsdottir
ASCO24Prostatacancer Play the Video 8:20
Back to top